| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/03/2009 | EP2063869A2 Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations |
| 06/03/2009 | EP2063868A1 Pharmaceutical compositions containing rosuvastatin calcium |
| 06/03/2009 | EP2063867A2 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 06/03/2009 | EP2063866A1 Preparation of glassified biological reagents |
| 06/03/2009 | EP2063865A1 Long term 24 hour intestinal administration of levodopa/carbidopa |
| 06/03/2009 | EP2063864A2 Edible water-soluble film containing a foam reducing flavoring agent |
| 06/03/2009 | EP2063863A2 Drug electrotransport with hydration measurement of hydratable reservoir |
| 06/03/2009 | EP2063862A2 Pharmaceutical formulation for use in hiv therapy |
| 06/03/2009 | EP2063861A2 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 06/03/2009 | EP2063709A2 Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| 06/03/2009 | EP2063708A2 Liquid pharmaceutical formulations for oral administration of a cgrp antagonist |
| 06/03/2009 | EP2063703A1 Method of improving renal function |
| 06/03/2009 | EP1928597B1 Method for the attachment of nanoparticles to substrate particles |
| 06/03/2009 | EP1888223B8 Method and device for encapsulating materials in liposomes comprising a freely adaptable membrane structure |
| 06/03/2009 | EP1863469A4 A topical analgesic composition |
| 06/03/2009 | EP1732535B1 Injectable composition for the treatment of cancers |
| 06/03/2009 | EP1678103B1 Process for the preparation of 1-octene |
| 06/03/2009 | EP1480618B1 Sustained release drug formulations containing a carrier peptide |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1379197A4 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| 06/03/2009 | EP1366759B1 Tablets quickly disintegrating in oral cavity |
| 06/03/2009 | EP1267840B1 Granulated particles with masked taste |
| 06/03/2009 | EP1207830B1 Absorbent foam material and an absorbent structure containing said foam material |
| 06/03/2009 | EP1187636B1 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 06/03/2009 | EP1035836B1 Composition comprising an enzym, a stabilizer for the enzym and a process for ameliorating the stability of the enzyme, to prevent its degradation, to protect it and/or to immobilise it |
| 06/03/2009 | CN101448489A Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 06/03/2009 | CN101448488A Colonic drug delivery formulation |
| 06/03/2009 | CN101448487A Oral controlled release formulation for sedative and hypnotic agents |
| 06/03/2009 | CN101448486A A composition for inactivating an enveloped virus |
| 06/03/2009 | CN101448485A Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
| 06/03/2009 | CN101444495A Vitamin E microcapsule preparation method |
| 06/03/2009 | CN101444494A Efficient long-acting sustained-release preparation of slightly soluble medicine and preparation method thereof |
| 06/03/2009 | CN101444493A Lovastatin dispersing tablet and preparation method thereof |
| 06/03/2009 | CN101444492A Lomefloxacin hydrochloride lyophilized powder for injection and preparation method therefor |
| 06/03/2009 | CN101444491A Ozagrel sodium microballoon lyophilized preparation and preparation method thereof |
| 06/03/2009 | CN101444490A Injection preparation containing anhydrogalactitol and preparation method thereof |
| 06/03/2009 | CN101444489A Astragalus polyose pellet and preparation method thereof |
| 06/03/2009 | CN101444488A Folic acid pellet and preparation method thereof |
| 06/03/2009 | CN101444487A Vitamin E micropill and preparation method thereof |
| 06/03/2009 | CN101444486A Water-soluble drug sustained-release microsphere and preparation method and applications thereof |
| 06/03/2009 | CN101444485A Gemcitabine liposome and preparation method thereof |
| 06/03/2009 | CN101444484A Suspension emulsion of florfenicol, preparation method and application thereof |
| 06/03/2009 | CN101444483A Sustained-release preparation containing chemotherapy synergist for treating solid tumors |
| 06/03/2009 | CN101444482A Sustained-release injection containing nitrosourea drugs |
| 06/03/2009 | CN101444481A Tropicamide eye drops without bacteria inhibitor and the preparation method thereof |
| 06/03/2009 | CN101444480A Spirulina polysaccharide eye drop, and preparation method and application thereof |
| 06/03/2009 | CN101444479A Lapatinib injection and preparation method thereof |
| 06/03/2009 | CN101444478A Injection preparation containing active constituent adefovir dipivoxil and preparation method thereof |
| 06/03/2009 | CN101444477A Azithromycin ophthalmic instant molding gel and preparation method thereof |
| 06/03/2009 | CN101444476A New microsphere and method for producing the same |
| 06/03/2009 | CN100494256C Polymer composite with internally distributed deposition matter |
| 06/03/2009 | CN100493648C Implantable pressure-activated micro-valve |
| 06/03/2009 | CN100493647C Sustained release of an active agent using an implantable system |
| 06/03/2009 | CN100493642C Powder inhaler |
| 06/03/2009 | CN100493613C A method to improve surface properties of pharmaceutical tablets |
| 06/03/2009 | CN100493611C Liposome and its preparation process |
| 06/03/2009 | CN100493609C Medicine composition for treating malignant tumours and application |
| 06/03/2009 | CN100493606C Use of human lysozyme in preparing medicines for cutaneous pruritus |
| 06/03/2009 | CN100493605C Use of human lysozyme in preparing anti-virus medicines for influenza |
| 06/03/2009 | CN100493595C Infrared cough relieving paste |
| 06/03/2009 | CN100493561C Laiyang pear buccal tablet and novel use of Laiyang pear oral formulation |
| 06/03/2009 | CN100493545C Process for preparing kidney-tonifying wolfberry fruit capsule |
| 06/03/2009 | CN100493531C Chinese medicine for treating diabetes |
| 06/03/2009 | CN100493523C Wolf'sclaw (Selaginella moellendorffii Hieron)dry powder extracted using alcohol, and its preparation method |
| 06/03/2009 | CN100493515C Nano emulsion containing ginsenoside, preparation method and usage |
| 06/03/2009 | CN100493501C Scopolamine hydrobromide dry powder inhalant for nose and preparing method |
| 06/03/2009 | CN100493495C Novel schisandra fruit soft capsule formulation and its preparation method |
| 06/03/2009 | CN100493494C American ginseng oral disintegration tablet and its preparing process |
| 06/03/2009 | CN100493493C Shuanghuanglian gel for eyes |
| 06/02/2009 | US7542801 System and method for monitoring power source longevity of an implantable medical device |
| 06/02/2009 | US7541385 Formoterol or derivative in water for long term storage stability; nebulized aerosol |
| 06/02/2009 | US7541350 Formulation containing anti-inflammatory androstane derivative |
| 06/02/2009 | US7541347 Controlled release carrier selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, and polyvinylpyrrolidone; improved pharmacokinetics as compared to immediate-release minocycline hydrochloride; side effect reduction |
| 06/02/2009 | US7541167 porous glass composite gel of water and polymer network made using an alkoxosilane derivative; group alterable charge, and hydrophobic and hydrophilic groups; separation media, drug delivery vehicles, and electric and mechanical actuators |
| 06/02/2009 | US7541050 Two-layered olefin-based resin pellets for insecticidal resin composition |
| 06/02/2009 | US7541048 a blends comprising ethylene-vinyl acetate copolymer and poly(alkyl(meth)acrylates or poly(aromatic(meth)acrylates); implantable medical device; permit stents releasing the bioactive agent over time in vivo; provide clear coats, durability, biocompatibility, and release kinetics; drug delivery device |
| 06/02/2009 | US7541047 Method for production of shaped body for treating wounds in milk producing animals |
| 06/02/2009 | US7541042 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 06/02/2009 | US7541041 Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans |
| 06/02/2009 | US7541037 Oxygen-barrier property enhancer is added to yeast cell wall fractions; antisticking agents; packaging |
| 06/02/2009 | US7541022 Pharmaceutical formulations for dry powder inhalers |
| 06/02/2009 | US7541021 Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation |
| 06/02/2009 | CA2526954C Antibiotics containing bone substitute material with sustained active substance release |
| 06/02/2009 | CA2512475C Compositions and methods for combination antiviral therapy |
| 06/02/2009 | CA2396223C Instant granules and process for their formulation |
| 06/02/2009 | CA2387143C Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 06/02/2009 | CA2386890C Artificial tear replacement solution |
| 06/02/2009 | CA2366793C Propofol formulation with enhanced microbial characteristics |
| 06/02/2009 | CA2356774C Method and device for preparing a medical fluid |
| 06/02/2009 | CA2350425C Use of an insulin sensitiser for the treatment of type 2 diabetes mellitus |
| 06/02/2009 | CA2349719C Controlled delivery of antidepressants |
| 06/02/2009 | CA2349633C A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 06/02/2009 | CA2340416C Co-lyophilized complex of a nucleic acid vector and a formulating agent |
| 06/02/2009 | CA2326137C Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 06/02/2009 | CA2304950C Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 06/02/2009 | CA2257329C Nebulized budesonide for the treatment of respiratory diseases |
| 06/02/2009 | CA2244089C Dermal penetration enhancers and drug delivery systems involving same |
| 06/02/2009 | CA2226548C Lyophilized hepatocyte growth factor preparations |
| 06/02/2009 | CA2158475C Composition and method for reducing toxicity of biologically-active factors |
| 05/30/2009 | CA2612999A1 Modified release composition of at least one form of venlafaxine |